Related Experiment Video
Updated: Aug 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Computer-adjusted dosage of anticoagulant therapy improves the quality of anticoagulation
G Chatellier1, I Colombet, P Degoulet
1Broussais University Hospital, Paris, France.
Objective:
Risks and benefits of anticoagulant therapy depend directly of the quality of anticoagulation. We performed a meta-analysis of published randomized trials to assess the overall effectiveness of computer-based prescription systems on the quality of anticoagulation.
Design:
Randomized controlled trials were identified through electronic searches of the Medline database (1966-1997) and systematic analyses of the references of articles. Two investigators selected relevant papers and summarized data from the studies.
Methods:
The outcome variable was the proportion of days within the target range of anticoagulation. A pooled estimate of the common odds ratio of being in the target range and its confidence interval was obtained by the Mantel-Haenszel method.
Results:
Seven trials having included 1217 patients were identified. Computer systems were based on a pharmacokinetic-pharmacodynamic model and a bayesian prediction method. Most of them concerned the oral anticoagulant warfarin. The global odds ratio of being in the target range was 1.58 [95% CI: 1.34-1.86], thus meaning that the use of a computer for anticoagulation optimization increased by 58% the proportion of visits where patients were appropriately treated. The proportion of clinical events was too low for allowing a summary analysis.
Conclusion:
Evidence from randomized controlled trials supports the effectiveness of computer-aided anticoagulant prescription. Diffusion of these systems in ambulatory care could increase the benefit/risk ratio of anticoagulant treatment at a low cost.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Dosage Regimen: Individualization
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Venous Thrombosis III: Interprofessional Care

